Spironolactone and Lin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spironolactone (spironolactone) and Lin (flaxseed oil). Common drug interactions include decreased appetite among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Spironolactone and Lin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Lin?

Lin has active ingredients of flaxseed oil. eHealthMe is studying from 463 Lin users. Check the latest studies of Lin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

14 people who take Spironolactone and Lin together, and have interactions are studied.

Spironolactone and Lin drug interactions.

What are the common drug interactions of Spironolactone and Lin, by gender? *:

female:

Decreased appetite
Headache (pain in head)
Hot flush (sudden feelings of heat)
Nausea (feeling of having an urge to vomit)
Pneumonia
Renal impairment (severely reduced kidney function)
Scar
Skin disorder (skin disease)
Sunburn
Urinary incontinence (inability to control the flow of urine and involuntary urination)

male:

Chest pain
Gynaecomastia (enlargement of the gland tissue of the male breast)
Hydrocele
Drug intolerance (drug sensitivity)
Cardiac failure congestive
Dyspnoea exertional (breathlessness or shortness of breath)
Oedema (fluid collection in tissue)

What are the common drug interactions of Spironolactone and Lin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chest pain
Gynaecomastia (enlargement of the gland tissue of the male breast)
Hydrocele
Drug intolerance (drug sensitivity)

50-59:

n/a

60+:

Pruritus (severe itching of the skin)
Breast cancer metastatic
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Abdominal pain upper
Asthenia (weakness)
Blood pressure decreased
Breast mass
Cardiac failure congestive
Cough
Dementia (madness)

What are the existing conditions these people have? *

Primary Hyperaldosteronism (too much aldosterone is produced by the adrenal glands): 3 people, 21.43%
Immunodeficiency Common Variable: 3 people, 21.43%
Hyperaldosteronism: 3 people, 21.43%
Primary Immunodeficiency Syndrome: 2 people, 14.29%
Incontinence (lack of moderation or self-control): 2 people, 14.29%
Type 1 Diabetes: 1 person, 7.14%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 7.14%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 7.14%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and Lin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously